Special Interest Groups

A Special Interest Group (SIG) is a group of ISoP members acting as volunteers and working on a specific and relevant topic which is within the scope and aims of ISoP.

Currently there are established SIGs on
‘Risk communication’,
‘Women’s medicines’,
‘Risk Minimisation Methods for Asian countries’,
‘Herbal and Traditional Medicines’,
‘PV Professional Qualification Framework’,
‘Medication Errors’,
‘Vaccine surveillance’
‘Pharmacogenomics’.

Guideline
Please click here for the latest SIG guideline – or contact ISoP Administration for more information.

Women’s Medicine Group

Women, half of our worldwide population, take medicines throughout their lifetime. This SIG focusses on the proper use of medicines, their benefits and harms.

Risk Communication Group

This SIG deals with all aspects of risk communication as a sub-discipline of safety surveillance and risk mitigation of medicines.

Risk Minimisation Methods for Asian countries

The focus of this SIG will be to elaborate and deliver risk minimization methods and strategies able to fit particularly the needs of countries in Asia.

Herbal and Traditional Medicines Group

Exploring issues relating to the safety and Pharmacovigilance of herbal and traditional medicines.

Pharmacovigilance Professional Qualification Framework Group

Responding to the need of harmonisation in professional pharmacovigilance qualifications.

Medication Errors

Ensuring the safe and effective use healthcare products is a key objective for all who work in pharmacovigilance, patients and all other stakeholders.

Vaccine Surveillance

Recent years have brought new challenges to the field of vaccine safety surveillance.

Pharmacogenomics

There is large interindividual variability in drug response. Some of the variation is related to inherited characteristics of the genome. These genomic variations may relate to pharmacokinetics (PK) or pharmacodynamics (PD) or to individual’s susceptibility.